Makers Lab Peer Comparison

BSE: 506919

₹203.15

₹3.94 (1.98%)

As on 15-Oct-2026IST

Market cap

₹121 Cr

Revenue (TTM)

₹148 Cr

P/E Ratio

35.4

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	121	18,056	17,506	17,424	15,984
Revenue (₹ Cr)	148	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	11.17	273.51	678.07	735.15	666.92
Net Margin (%)	7.43	16.19	28.10	26.88	20.60
RoE (%)	4.76	11.15	19.73	19.16	18.75
Price to Earnings	35.35	60.73	26.31	23.70	24.82
Price-To-Book	1.56	6.72	4.77	3.95	3.96

Income Statement (₹ Cr)

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	148.37	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	150.42	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	129.68	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	18.69	478.55	796.58	941.63	1,139.61
Depreciation	4.54	126.01	78.10	57.58	281.06
EBIT	14.15	352.55	718.48	884.05	858.55
Interest	0.74	52.11	0.88	7.69	190.64
Other Income	2.05	7.37	125.96	165.62	7.45
Exceptional Items	0.00	12.16	0.00	-49.16	-17.24
Profit before Tax	15.47	319.96	843.56	992.82	658.12
Provision for Tax	4.30	46.45	165.49	257.67	-8.80
Profit after Tax	11.17	273.51	678.07	735.15	666.92

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	72.92	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	-7.75	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	10.12	266.35	28.74	91.50	1,392.75
Current Liabilities	34.02	848.06	385.94	627.48	2,077.10
Total Liabilities	166.62	3,705.61	4,037.51	4,921.88	7,246.72

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	73.14	2,525.44	1,291.22	770.28	5,617.77
Current Assets	86.95	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	166.62	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	4.76	657.97	0.57	2.50	2,309.68
Net Current Assets	52.93	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	4.71	160.01	17.53	370.49	51.57

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	14.29	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-14.69	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	0.35	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	-0.05	29.88	-105.52	-392.41	-145.00

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	15.83	11.43	24.97	23.39	14.47
ROE (%)	4.76	11.15	19.73	19.16	18.75
ROA (%)	7.10	7.80	18.69	14.95	9.26
EBIT Margin (%)	9.54	20.95	31.41	34.40	26.58
Net Margin (%)	7.43	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	17.60	27.91	15.01	10.69	9.59
EBIT Growth (%)	185.19	58.32	18.45	24.14	16.84
Net Profit Growth (%)	-13.38	149.56	19.61	-9.09	62.68
EPS Growth (%)	-61.24	-3.57	17.73	14.40	67.41
Book Value Growth (%)	3.43	9.67	26.75	-0.34	36.71

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	35.38	64.42	26.31	22.59	24.20
Price / Book Value	1.56	6.72	4.77	3.95	3.96
Dividend Yield (%)	0.00	0.07	0.35	1.97	0.00
EV/EBITDA	6.07	39.01	20.71	15.20	15.99
Market Cap (₹ Cr)	79.77	6,819.66	11,439.22	21,592.90	17,980.08

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.01	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.04	0.16	0.00	0.00	0.12
Current Ratio	2.56	1.31	6.70	6.06	0.74
Quick Ratio	1.23	0.88	5.59	5.31	0.53
Interest Coverage	21.93	7.14	959.59	130.11	4.45

	Makers Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	13.39	30.84	36.10	7.07	21.07
Asset Turnover	0.94	0.48	0.63	0.52	0.45
Receivable days	62.18	113.81	121.68	26.06	63.88
Inventory Days	102.52	84.76	63.83	65.95	43.27
Payable days	90.08	101.94	108.28	81.01	151.85
Cash Conversion Cycle	74.62	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.